FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry and provides a pharmaceutical composition for treating Gaucher's disease, which contains as an active ingredient lyophilised plant cells which express recombinant human glucocerebrosidase, a pharmaceutically acceptable carrier, where said pharmaceutical composition is intended for oral administration and where said human glucocerebrosidase has high-mannose glycosylation.
EFFECT: invention enables to obtain an effective pharmaceutical composition for treating Gaucher's disease with high enzyme biological activity owing to high-mannose glycosylation thereof.
16 cl, 21 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRODUCTION OF HIGH-MANNOSE PROTEINS IN VEGETABLE CULTURES | 2004 |
|
RU2385928C2 |
| PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION | 2008 |
|
RU2479629C2 |
| PRODUCING ACTIVE HIGHLY PHOSPHORYLATED HUMAN LYSOSOMAL SULPHATASE ENZYMES AND USE THEREOF | 2009 |
|
RU2510820C2 |
| LYSOSOMAL DISEASE ACCUMULATION ENZYME | 2017 |
|
RU2741116C2 |
| MEDICINE ON BASIS OF BIFUNCTIONAL ANTIBODY FOR TREATMENT OF II TYPE MUCOPOLYSACCHARIDOSIS | 2016 |
|
RU2673038C2 |
| LYSOSOMAL STORAGE DISORDER ENZYME | 2011 |
|
RU2575074C2 |
| METHOD FOR CONTROLLING GLYCOSYLATION OF RECOMBINANT GLYCOPROTEIN | 2015 |
|
RU2670889C9 |
| METHOD FOR PURIFICATION OF IMIGLUCERASE | 2017 |
|
RU2668158C1 |
| PRODUCTION OF ACTIVE HIGHLY PHOSPHORYLATED N-ACETYLGALACTOSAMINE-6-SULPHATASE AND USE THEREOF | 2011 |
|
RU2607376C2 |
| METHODS AND MATERIALS FOR TREATMENT OF POMPE DISEASE | 2013 |
|
RU2644258C2 |
